Shares of Sarepta sank 36% before the bell on Tuesday after a trial for two gene-targeted therapies for a muscle-wasting ...
The streak continues. For all three of Gonzaga's preseason events - Kraziness in the Kennel, the exhibition against Northwest ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Rochester Regional Health is launching a new genetic screening program called GenoWell. It’s aimed at helping participants ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...
The move follows similar initiatives by players like Syngene, Laurus Labs, and Aragen. Industry analysts see Bharat Biotech’s ...
Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...
Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...
Strong enthusiasm for novel modalities is tempered by neurologists’ demands for clinically meaningful endpoints and data superiority, according to .EXTON, PA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ’ ...
UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...
News-Medical.Net on MSN
Researchers develop a versatile tool for controlling gene activity
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback